Showing 61 - 80 results of 345 for search '"Alzheimer disease"', query time: 0.09s Refine Results
  1. 61
  2. 62
  3. 63
  4. 64

    Striatal Hypodensities, Not White Matter Hypodensities on CT, Are Associated with Late-Onset Depression in Alzheimer's Disease by Jessica A. Brommelhoff, Bryan M. Spann, John L. Go, Wendy J. Mack, Margaret Gatz

    Published 2011-01-01
    “…Compared to individuals with Alzheimer's disease and no depression, individuals with Alzheimer's disease and late-onset depression (first depressive episode at age 60 or over) had a greater number of striatal hypodensities (gray matter hypodensities in the caudate nucleus and lentiform nucleus). …”
    Get full text
    Article
  5. 65
  6. 66
  7. 67
  8. 68

    Exploring peripheral fluid biomarkers for early detection of Alzheimer's disease in Down syndrome: A literature review by Charlotte Jacob, Marleen Tollenaere, Hanane Kachar, Marie-Claude Potier, Peter Paul De Deyn, Debby Van Dam

    Published 2025-01-01
    “…People with Down Syndrome (DS) are at high risk of developing Alzheimer's disease dementia (AD) and cerebral amyloid angiopathy, which is a critical factor contributing to dementia in sporadic AD. …”
    Get full text
    Article
  9. 69
  10. 70
  11. 71

    Multimodal MRI Neuroimaging Biomarkers for Cognitive Normal Adults, Amnestic Mild Cognitive Impairment, and Alzheimer's Disease by Ai-Ling Lin, Angela R. Laird, Peter T. Fox, Jia-Hong Gao

    Published 2012-01-01
    “…This paper discusses recent findings of the multimodal MRI in the context of surrogate biomarkers for identifying the risk for AD in normal cognitive (NC) adults, brain anatomical and functional alterations in amnestic mild cognitive impairment (aMCI), and Alzheimer's disease (AD) patients. Further developments of these techniques and the establishment of promising neuroimaging biomarkers will enhance our ability to diagnose aMCI and AD in their early stages and improve the assessment of therapeutic efficacy in these diseases in future clinical trials.…”
    Get full text
    Article
  12. 72
  13. 73

    Pharmacophore-based virtual screening for identification of marine sponge bioactive compound inhibitors against Alzheimer's disease by Suruthi SS, Prashanth KK, Baskaran A

    Published 2025-06-01
    “…Alzheimer's disease is a hereditary neurodegenerative disease that occurs sporadically and causes amnestic cognitive impairment. …”
    Get full text
    Article
  14. 74
  15. 75

    Ketamine does not rescue plaque load or gap detection in the 5XFAD mouse model of Alzheimer's disease by Alexa L. Wright, Aldis P. Weible, Olivia B. Estes, Michael Wehr

    Published 2025-02-01
    “…Recent evidence suggests that early sensory and behavioral deficits in Alzheimer's disease could be caused by synaptic disruption that occurs before irreversible neuropathology. …”
    Get full text
    Article
  16. 76
  17. 77
  18. 78
  19. 79
  20. 80

    Nanoparticle Therapy Is a Promising Approach in the Management and Prevention of Many Diseases: Does It Help in Curing Alzheimer Disease? by Lamyaa M. Kassem, Nada A. Ibrahim, S. Ayesha Farhana

    Published 2020-01-01
    “…Primary research studies in using nanoparticles to cure Alzheimer disease (AD) are promising but are still in need for more investigations. …”
    Get full text
    Article